Agios Pharmaceuticals Inc (NASDAQ:AGIO) - Share price - Overview

Stock Report

Agios Pharmaceuticals Inc AGIO

Last Price
$69.89

Day Change
1.74|2.55%

As of 19/01/2018
17:58:30 EST | USD
Minimum 15 Minutes Delay.

Last Close68.15
Day Range67.00 - 72.81
Mkt Cap3.41Bil
52-Wk Range39.24 - 76.02
Yield %-
ISINUS00847X1046
Volume4,119,632
P/E-11.11
P/S56.18
P/CF-11.98

Share Price

Financials
201420152016
More ...
Income Statement
Revenue65.3659.1269.89
Operating Income-54.13-118.70-200.99
Net Income-53.50-117.73-198.47
Basic EPS-1.59-3.15-5.07
Avg. Diluted Shares Outstanding343739
Balance Sheet
Current Assets359.55337.33559.89
Non Current Assets132.3682.7459.20
Total Assets491.90420.07619.09
Current Liabilities61.0952.8988.43
Total Liabilities67.5474.95260.50
Total Equity424.37345.12358.59
Cash Flow
Operating Cash Flow-59.35-76.9538.56
Capital Expenditure-2.22-20.16-9.92
Free Cash Flow-61.57-97.1128.65

In millions, except "Basic EPS". Currency is USD.

Company Profile

Agios Pharmaceuticals Inc is a biopharmaceutical company which focuses on developing treatments geared towards cancer and rare genetic disorders of metabolism. It also emphasizes on developing potentially transformative small-molecule medicines.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

287
Key Stats
More ...
Price/Earning TTM-10.83
Price/Book7.39
Price/Sales TTM54.80
Rev Growth (3 year avg)39.86
EPS Growth (3 year avg)-
Operating Margin % TTM-287.57
Net Margin % TTM-283.97
ROE TTM-56.41
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.